Related Experiment Videos
[Pancreas transplantation]
1Department of Surgery, University Hospital and Clinic, Minneapolis, Minnesota.
Abstract:
Pancreas transplantation is performed to establish a normoglycemic state, insulin-independent, in a diabetic type I recipient. Abundant evidence supports the concept that lesions developing in the eyes, nerves, kidneys and other organ systems are secondary to disordered metabolism and that restoration of normoglycemia will favorably influence their evolution. The need to provide antirejection, therapy currently confines the application of pancreas transplantation to three main groups of recipients: 1. patients who need a kidney transplant to treat end-stage diabetic nephropathy, 2. patients who received a renal transplant and have progressive systemic diabetic disease, 3. diabetics who are severely handicapped in their day-to-day lives because of difficulty with metabolic control. A significant improvement in the results of pancreas transplant has progressively occurred worldwide and several controlled studies are beginning to provide evidence of the favorable effect on secondary complications. The quality of life of these patients is also improved by a functioning graft.
Insights
Pancreas transplantation restores normal blood sugar levels in type 1 diabetes patients. This improves long-term health outcomes and quality of life by preventing or slowing diabetic complications.
Area of Science:
- Transplantation immunology
- Endocrinology
- Metabolic disease research
Context:
- Type 1 diabetes mellitus (T1DM) leads to microvascular and macrovascular complications.
- Diabetic complications affect the eyes, nerves, kidneys, and other organs.
- Pancreas transplantation is a therapeutic option for select T1DM patients.
Purpose:
- To establish insulin independence and normoglycemia in T1DM recipients.
- To halt or reverse the progression of secondary diabetic complications.
- To improve the overall quality of life for patients with challenging metabolic control.
Summary:
- Pancreas transplantation aims to achieve a normoglycemic, insulin-independent state in type 1 diabetes patients.
- Evidence suggests that restoring normoglycemia favorably influences the evolution of diabetic lesions.
- Current applications are primarily for patients with end-stage diabetic nephropathy, those with progressive disease post-kidney transplant, or those with severe metabolic control issues.
Impact:
- Significant improvements in pancreas transplant outcomes have been observed globally.
- Controlled studies are emerging to validate the beneficial effects on secondary diabetic complications.
- A functioning pancreas graft demonstrably enhances the quality of life for transplant recipients.